Grassmann F - Search Results

1

Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors.

Yang H, Holowko N, Grassmann F, Eriksson M, Hall P, Czene K. Yang H, et al. Among authors: grassmann f. BMC Med. 2020 Aug 25;18(1):225. doi: 10.1186/s12916-020-01690-y. BMC Med. 2020. PMID: 32838791 Free PMC article.

2

Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns.

Ugalde-Morales E, Grassmann F, Humphreys K, Li J, Eriksson M, Tobin NP, Borg Å, Vallon-Christersson J, Hall P, Czene K. Ugalde-Morales E, et al. Among authors: grassmann f. Int J Cancer. 2021 Feb 15;148(4):884-894. doi: 10.1002/ijc.33270. Epub 2020 Sep 5. Int J Cancer. 2021. PMID: 32856720 Free PMC article.

3

Mammographic features are associated with cardiometabolic disease risk and mortality.

Grassmann F, Yang H, Eriksson M, Azam S, Hall P, Czene K. Grassmann F, et al. Eur Heart J. 2021 Sep 7;42(34):3361-3370. doi: 10.1093/eurheartj/ehab502. Eur Heart J. 2021. PMID: 34338750 Free PMC article.

4

Risk of heart disease following treatment for breast cancer - results from a population-based cohort study.

Yang H, Bhoo-Pathy N, Brand JS, Hedayati E, Grassmann F, Zeng E, Bergh J, Bian W, Ludvigsson JF, Hall P, Czene K. Yang H, et al. Among authors: grassmann f. Elife. 2022 Mar 16;11:e71562. doi: 10.7554/eLife.71562. Elife. 2022. PMID: 35293856 Free PMC article.

5

Interval breast cancer is associated with interferon immune response.

Ugalde-Morales E, Grassmann F, Humphreys K, Li J, Eriksson M, Tobin NP, Lindström LS, Vallon-Christersson J, Borg Å, Hall P, Czene K. Ugalde-Morales E, et al. Among authors: grassmann f. Eur J Cancer. 2022 Feb;162:194-205. doi: 10.1016/j.ejca.2021.12.003. Epub 2022 Jan 10. Eur J Cancer. 2022. PMID: 35026490 Free article.

6

Interval breast cancer is associated with other types of tumors.

Grassmann F, He W, Eriksson M, Gabrielson M, Hall P, Czene K. Grassmann F, et al. Nat Commun. 2019 Oct 22;10(1):4648. doi: 10.1038/s41467-019-12652-1. Nat Commun. 2019. PMID: 31641120 Free PMC article.

7

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial.

He W, Eriksson M, Eliasson E, Grassmann F, Bäcklund M, Gabrielson M, Hammarström M, Margolin S, Thorén L, Wengström Y, Borgquist S, Hall P, Czene K. He W, et al. Among authors: grassmann f. Ann Oncol. 2021 Oct;32(10):1286-1293. doi: 10.1016/j.annonc.2021.07.005. Epub 2021 Jul 18. Ann Oncol. 2021. PMID: 34284099 Free article. Clinical Trial.

8

A systems genomics approach to uncover the molecular properties of cancer genes.

Grassmann F, Pawitan Y, Czene K. Grassmann F, et al. Sci Rep. 2020 Oct 27;10(1):18392. doi: 10.1038/s41598-020-75400-2. Sci Rep. 2020. PMID: 33110144 Free PMC article.

9

Lymph node metastases in breast cancer: Investigating associations with tumor characteristics, molecular subtypes and polygenic risk score using a continuous growth model.

Isheden G, Grassmann F, Czene K, Humphreys K. Isheden G, et al. Among authors: grassmann f. Int J Cancer. 2021 Sep 15;149(6):1348-1357. doi: 10.1002/ijc.33704. Epub 2021 Jun 21. Int J Cancer. 2021. PMID: 34097750 Free article.

10

CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer.

He W, Grassmann F, Eriksson M, Eliasson E, Margolin S, Thorén L, Hall P, Czene K. He W, et al. Among authors: grassmann f. J Clin Oncol. 2020 Feb 20;38(6):548-557. doi: 10.1200/JCO.19.01535. Epub 2019 Dec 4. J Clin Oncol. 2020. PMID: 31800347 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page